Key points:<p>1) Seroprevalance of antibodies in just 5% of the population in one of the hardest hit European countries<p>2) No difference in infection rates based on gender<p>3) Large variations in seroprevalence based on symptoms:<p>No symptoms - 2.8%;
Several Symptoms - 12.3%;
Loss of smell - 40.1%<p>Actual cases 8x the official count and IFR of just over 1%<p>This study is the largest yet and weakens the case for the pursuit of herd immunity without vaccines (28k fatalities with an infection rate of just 5%)